Breaking News
39 minutes ago
Mrudula Kulkarni
Sun Pharma joins the 2026 S&P Dow Jones Best-in-Class World Index, one of 317 global companies and 25 from India recognised for industry-leading sustainability performance.
Mrudula Kulkarni
FDA's final DHT guidance sets binding expectations for remote data acquisition in clinical trials, affecting protocol design and submission strategy.
Simantini Singh Deo

FDA updates its IND safety reporting resource, clarifying 21 CFR 312.32 thresholds, timelines, and submission requirements for active IND sponsors.
Simantini Singh Deo

FDA's Guidance Snapshot Pilot debuts with Master Protocols and Bayesian Methodology drafts, offering regulatory teams structured access to cross-cutting clinical trial guidance.
Simantini Singh Deo
